ACT Capital Management’s Enlivex Therapeutics ENLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$64K Hold
2022
Q2
$68K Sell
2022
Q1
$140K Hold
2021
Q4
$156K Sell
2021
Q3
$815K Hold
2021
Q2
$735K Buy